ArticlePharmaceutical research2013
Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.
Emily Gullotti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it